ESR1 and breast carcinoma: Further analysis showed that three breast cancer risk SNPs (rs2981578, rs35054928 and rs45631563) in the FGFR2 locus were responsible for reduced expression of FGFR2, conferred increased estrogen responsiveness and a higher risk of ER-positive IDC [99].